TIDMINHC
Induction Healthcare Group PLC
13 January 2021
Induction Healthcare Group PLC
("Induction", the "Company", or the "Group")
Royal Free selects Induction to deliver new patient portal
- Improving patient access to digital services
- High adoption since launch, with over 50,000 patients
registered
Induction, a leading healthcare technology company that helps
digitally transform hospitals, announces a contract with the Royal
Free London NHS Foundation Trust ("RFL"). Induction Zesty, a
leading provider of patient portals to NHS Hospitals, has delivered
the My RFL Care patient portal as the first phase of an ambitious
roadmap for RFL's digital patient services in the next two
years.
The My RFL Care portal launched in August 2020 and has had
significant traction with over 50,000 patients registering and
using the service in the first few months. 250,000 patients are
expected to adopt the service in the first year.
The RFL combines globally recognised clinical expertise with
local and friendly hospital care to represent the best of the NHS.
The trust is a world-leader in a range of specialist services,
including infectious diseases, immunology, kidney and liver
transplantation, cancer care, plastic surgery and vascular surgery.
The trust also runs internationally recognised clinical research
programmes and is a leading teaching hospital.
Induction Zesty are committed to transforming clinical pathways
in acute hospitals by putting the right technology in the hands of
the patient. This patient-centric, technology-driven vision
delivers superior patient outcomes while reducing whole-system
costs for hospitals. It alleviates the strain on hospital resources
and embeds a long-term foundation for future improvements.
Induction Joint CEO and Zesty founder, James Balmain, said:
"Partnering with Royal Free London, one of the largest and most
respected hospitals in the UK, is an important milestone for
Induction Zesty. In just a few months, tens of thousands of
patients have successfully registered and used the platform. We
look forward to supporting the Royal Free London in delivering
further enhanced functionality for their patient portal over the
coming months."
RFL Group Chief Digital Officer, Glenn Winteringham, said:
"The Induction Zesty team have done an outstanding job of
delivering the first phase of our digital programme in just eight
weeks which gives me a lot of confidence I have the right digital
partner to deliver our ambitious roadmap in the future. The early
results are very impressive with a high adoption rate among our
patients. I am excited by the potential this innovation has to make
a real difference to our patients as we address the overhang from
the COVID-19 pandemic."
- ENDS -
ENQUIRIES
Induction Healthcare Via FTI Consulting
Dr Hugo Stephenson, Joint Chief Executive
Officer
James Balmain, Joint Chief Executive Officer
Numis Securities (Nominated Adviser and
Broker) +44 (0) 207 260 1000
James Black / Freddie Barnfield / Huw Jeremy
/ Matthew Jones
FTI Consulting +44 (0) 203 727 1000
Jamie Ricketts / Elena Kalinskaya / Sam Purewal
About Induction
Induction (INHC.LSE) is a UK-based leading healthcare technology
company enabling the digital transformation of secondary care. This
is done by rolling up smaller solutions that are loved by doctors,
hospital staff and patients and giving those solutions the
infrastructure, credibility and interoperability they need to
achieve commercial success at scale.
Over 190,000 hospital doctors across multiple territories,
including the UK, Ireland, Australia and South Africa - as well as
a rapidly growing cohort of over 140,000 patients - choose to use
Induction products over traditional methods of managing care.
Induction helps healthcare professionals deliver better care
more efficiently via a suite of technology platforms, including
Induction Switch, Induction MicroGuide, Induction Zesty and
Induction HealthStream.
Induction Zesty is a leading provider of patient portals to NHS
Hospitals in the UK, enabling hospital patients to manage their
care direct from their smartphone. Induction Zesty removes the
friction from everyday health related tasks, like booking and
managing appointments, enabling remote patient monitoring, and
sharing copies of electronic medical records.
Induction HealthStream is a proprietary data integration
platform that reads and writes patient demographic, appointment and
clinical record data between a growing number of hospital EHR
systems and the Induction platforms.
Induction Switch is the number one healthcare collaboration app
in the UK, used by the majority of hospital doctors within the NHS.
The app helps to increase productivity and enhance communication by
securely sharing phone numbers and bleeps, bookmarks, documents and
messages in a clinical setting.
Induction MicroGuide provides medical organisations, including
most hospital trusts within the NHS, with the ability to
collaboratively create, edit, and publish their own local medical
guidelines in a secure and locally administrated environment.
About Royal Free London NHS Foundation Trust
The Royal Free began as a pioneering organisation and continues
to play a leading role in the care of its patients. The Royal
Free's mission is to provide world class expertise and local care.
Established in 1828 by William Marsden, a newly qualified surgeon
shocked that he could not find treatment for a penniless young
woman, the Royal Free's founding principle was that they would take
in anyone who needed treatment - the first hospital in London to do
so and the only London hospital to stay open during the
19th-century cholera epidemics.
In the 21st century, the Royal Free London continues to lead
improvements in healthcare and is proud to have some of the best
clinical outcomes in the country.
This information is provided by Reach, the non-regulatory press
release distribution service of RNS, part of the London Stock
Exchange. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
NRAMZGMMNZZGMZM
(END) Dow Jones Newswires
January 13, 2021 02:00 ET (07:00 GMT)
Induction Healthcare (LSE:INHC)
Historical Stock Chart
From Apr 2024 to May 2024
Induction Healthcare (LSE:INHC)
Historical Stock Chart
From May 2023 to May 2024